The Drug Changing Medicine

By EMANUEL SARKEES The United States is in the middle of what researchers are calling one of the most significant pharmacological developments in modern medicine. GLP-1 receptor agonists, the drug class behind Ozempic and Wegovy, have become able to reduce obesity, lower cardiovascular risk, control blood sugar, and show signals improving areas like addiction and…

Read More

Insurers Hedge on Trump-Backed Pledge To Improve Denials Process

One year after the Trump administration announced that dozens of health insurers had signed a six-part pledge promising to reduce barriers to doctor-recommended care, some insurers now say they won’t implement all the promised initiatives. Meanwhile, patients, their advocates, and clinicians say little has improved. “It has never been this bad for patients,” said U.S….

Read More

WHO’s 2026 Cancer Report

This month, the World Health Organization (WHO) released its annual report on cancer titled Global status report on cancer 2026: the future we choose together. I provide a high level Q&A summary of see key statistics. How many cancer cases were there in 2024? “In 2024, there were 20.6 million new cancer cases worldwide5 (19.5…

Read More